PHARMACEUTICAL EPIDEMIOLOGIES
\fˌɑːmɐsˈuːtɪkə͡l ˌɛpɪdˌɛmɪˈɒləd͡ʒɪz], \fˌɑːmɐsˈuːtɪkəl ˌɛpɪdˌɛmɪˈɒlədʒɪz], \f_ˌɑː_m_ɐ_s_ˈuː_t_ɪ_k_əl ˌɛ_p_ɪ_d_ˌɛ_m_ɪ__ˈɒ_l_ə_dʒ_ɪ_z]\
Sort: Oldest first
-
The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1 (1); J Pharmacoepidemiol 1990;1 (1))
By DataStellar Co., Ltd
Word of the day
basidiomycota
- comprises fungi bearing the spores on basidium: Gasteromycetes (puffballs); Tiliomycetes (comprising orders Ustilaginales (smuts) and Uredinales (rusts)); Hymenomycetes (mushrooms; toadstools; agarics; bracket fungi); in some classification systems considered a division of kingdom comprises fungi bearing spores on a basidium; includes Gasteromycetes (puffballs) Tiliomycetes comprising the orders Ustilaginales (smuts) and Uredinales (rusts) Hymenomycetes (mushrooms, toadstools, agarics bracket fungi).